My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 719

    1.

    Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.

    Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE.

    Diabetes Care. 2002 Jun;25(6):1072-7.PMID: 12032117 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A low-sodium diet potentiates the effects of losartan in type 2 diabetes.

    Houlihan CA, Allen TJ, Baxter AL, Panangiotopoulos S, Casley DJ, Cooper ME, Jerums G.

    Diabetes Care. 2002 Apr;25(4):663-71.PMID: 11919122 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.

    Esmatjes E, Flores L, Iñigo P, Lario S, Ruilope LM, Campistol JM.

    Nephrol Dial Transplant. 2001;16 Suppl 1:90-3.PMID: 11369831 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.

    Agarwal R, Siva S, Dunn SR, Sharma K.

    Am J Kidney Dis. 2002 Mar;39(3):486-92.PMID: 11877567 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of losartan on urinary secretion of extracellular matrix and their modulators in type 2 diabetes mellitus patients with microalbuminuria.

    Woo V, Ni LS, Hak D, Berard L, Zhu F, Khan S, Ma GM, Penner B, Shen GX.

    Clin Invest Med. 2006 Dec;29(6):365-72.PMID: 17330452 [PubMed - indexed for MEDLINE]Related articles

    6.

    Transforming growth factor beta in hypertensives with cardiorenal damage.

    Laviades C, Varo N, Díez J.

    Hypertension. 2000 Oct;36(4):517-22.PMID: 11040229 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.

    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.

    Clin Nephrol. 2003 Nov;60(5):318-26.PMID: 14640237 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy.

    Yasuda G, Ando D, Hirawa N, Umemura S, Tochikubo O.

    Diabetes Care. 2005 Aug;28(8):1862-8.PMID: 16043724 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study]

    Goicolea I, Fernández González R, Piniés J, Garrido J, Martínez JM, Armenteros S, Moreno Carretero E.

    Nefrologia. 2002;22(2):170-8. Spanish. PMID: 12085418 [PubMed - indexed for MEDLINE]Related articles

    10.

    Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.

    Scaglione R, Argano C, Corrao S, Di Chiara T, Licata A, Licata G.

    J Hypertens. 2005 Mar;23(3):657-64.PMID: 15716710 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.

    Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.

    Nephrol Dial Transplant. 2003 Jun;18(6):1115-21.PMID: 12748343 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.

    Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marín R, Campistol JM.

    Nephrol Dial Transplant. 2003 Sep;18(9):1806-13.PMID: 12937228 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.

    Tan KC, Chow WS, Ai VH, Lam KS.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6.PMID: 11921421 [PubMed - indexed for MEDLINE]Related articles

    14.

    Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.

    Chan JC, Nicholls MG, Cheung CK, Law LK, Swaminathan R, Cockram CS.

    Diabetes Care. 1995 Jul;18(7):1001-6.PMID: 7555530 [PubMed - indexed for MEDLINE]Related articles

    15.

    Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.

    Vervoort G, Hertenberg F, Wetzels JF, Smits P.

    J Hypertens. 1998 Feb;16(2):245-50.PMID: 9535153 [PubMed - indexed for MEDLINE]Related articles

    16.

    Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

    Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

    J Nephrol. 2001 Nov-Dec;14(6):461-71.PMID: 11783602 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.

    Igarashi M, Hirata A, Kadomoto Y, Tominaga M.

    Endocr J. 2006 Aug;53(4):493-501. Epub 2006 Jul 10.PMID: 16829707 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.

    Chan JC, Critchley JA, Tomlinson B, Chan TY, Cockram CS.

    Am J Nephrol. 1997;17(1):72-80.PMID: 9057957 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.

    Zandbergen AA, Baggen MG, Lamberts SW, Bootsma AH, de Zeeuw D, Ouwendijk RJ.

    Ann Intern Med. 2003 Jul 15;139(2):90-6.PMID: 12859158 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity